Publications
-
1.
2013Eli Gilboa; James McNamara II; Fernando Pastor
Use of oligonucleotide aptamer ligands to modulate the function of immune receptors
Clinical Cancer Research. 2013;19(5):1054-1062. -
2.
2012Alexey Berezhnoy; C. Andrew Stewart; James O. Mcnamara II; William Thiel; Paloma Giangrande; Giorgio Trinchieri; Eli Gilboa
Molecular Therapy. 2012;20(6):1242-1250. -
3.
2012Thomas Blankenstein; Pierre G. Coulie; Eli Gilboa; Elizabeth M. Jaffee
The determinants of tumour immunogenicity
Nature Reviews Cancer. 2012;12(4):307-313.
Similar Experts
- Publications
- 267










- 127










- 143










- 116










Journals
-
Publications
-
14
-
13
-
9
-
9
-
8
Grants
-
1.
Gilboa Eli
Expressing New Tumor Antigens by Inhibition of Nonsense Mediated mRNA Decay
3/1/2011 - 2/29/2016
Sponsor: NATIONAL CANCER INSTITUTE
Funding: $ 777,814.00
-
2.
Gilboa Eli
Oligonucleotide aptamer ligands to reverse T cell anergy in HIV-infected patients
6/15/2010 - 5/31/2013
Sponsor: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Funding: $ 418,455.00
-
3.
Gilboa Eli
Development of Oligonucleotide-based CTLA-4 Inhibitors
4/1/2004 - 3/31/2010
Sponsor: NATIONAL CANCER INSTITUTE
Funding: $ 1,530,553.00
Institutional Network
-
Internal OrganizationsShared Pub.
-
2









-
External OrganizationsShared Pub.
-
65
-
20
-
8
-
7
-
6
-
4



